Literature DB >> 16111838

Selenite-induced apoptosis of osteoclasts mediated by the mitochondrial pathway.

Youn Wook Chung1, Tae Soo Kim, Soo Young Lee, Seoung Hoon Lee, Yongwon Choi, Nacksung Kim, Byung-Moo Min, Dae-Won Jeong, Ick Young Kim.   

Abstract

The possible effects of sodium selenite on mature osteoclasts were investigated. Incubation of osteoclast-like cells differentiated from RAW 264.7 cells with sodium selenite induced apoptosis as revealed by morphological changes, internucleosomal DNA fragmentation, and activation of caspase-3. Selenite also induced generation of the superoxide anion and reduced the number of free thiol groups in the osteoclast-like cells, suggestive of a shift to a more oxidizing intracellular environment. In addition, selenite induced protein aggregation by thiol cross-linking, loss of the mitochondrial membrane potential, and cytochrome c release in mitochondria isolated from the osteoclast-like cells. Finally, selenite-induced DNA fragmentation in osteoclasts was inhibited both by cyclosporin A, a blocker of the mitochondrial permeability transition pore, and by DEVD-CHO, a cell-permeable inhibitor of caspase-3. These results thus suggest that selenite induces apoptosis mediated by the mitochondrial pathway in mature osteoclasts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16111838     DOI: 10.1016/j.toxlet.2005.06.019

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  13 in total

1.  Systemic treatment with alpha-tocopherol and/or sodium selenite decreases the progression of experimental periodontitis.

Authors:  Nurgül Bas; Nezahat Arzu Kayar; Z Füsun Baba; Mustafa Cihat Avunduk; Seyfullah Haliloğlu; Nilgün Özlem Alptekin
Journal:  Clin Oral Investig       Date:  2020-09-28       Impact factor: 3.573

2.  Adjuvant selenium supplementation in the form of sodium selenite in postoperative critically ill patients with severe sepsis.

Authors:  Yasser Sakr; Vivian P L Maia; Clesar Santos; Julia Stracke; Mohamed Zeidan; Ole Bayer; Konrad Reinhart
Journal:  Crit Care       Date:  2014-04-09       Impact factor: 9.097

3.  Increased Cytotoxicity of Vanadium to CHO-K1 Cells in the Presence of Inorganic Selenium.

Authors:  Iwona Zwolak
Journal:  Bull Environ Contam Toxicol       Date:  2015-07-23       Impact factor: 2.151

Review 4.  High-dose intravenous selenium does not improve clinical outcomes in the critically ill: a systematic review and meta-analysis.

Authors:  William Manzanares; Margot Lemieux; Gunnar Elke; Pascal L Langlois; Frank Bloos; Daren K Heyland
Journal:  Crit Care       Date:  2016-10-28       Impact factor: 9.097

Review 5.  Supplementation of Micronutrient Selenium in Metabolic Diseases: Its Role as an Antioxidant.

Authors:  Ning Wang; Hor-Yue Tan; Sha Li; Yu Xu; Wei Guo; Yibin Feng
Journal:  Oxid Med Cell Longev       Date:  2017-12-26       Impact factor: 6.543

6.  Sodium selenate treatment mitigates reduction of bone volume following traumatic brain injury in rats.

Authors:  R D Brady; B L Grills; T Romano; J D Wark; T J O'Brien; S R Shultz; S J McDonald
Journal:  J Musculoskelet Neuronal Interact       Date:  2016-12-14       Impact factor: 2.041

Review 7.  Selenium in bone health: roles in antioxidant protection and cell proliferation.

Authors:  Huawei Zeng; Jay J Cao; Gerald F Combs
Journal:  Nutrients       Date:  2013-01-10       Impact factor: 5.717

8.  Structural changes in femoral bone tissue of rats after subchronic peroral exposure to selenium.

Authors:  Monika Martiniaková; Ivana Boboňová; Radoslav Omelka; Birgit Grosskopf; Robert Stawarz; Róbert Toman
Journal:  Acta Vet Scand       Date:  2013-02-01       Impact factor: 1.695

9.  Simultaneous subchronic exposure to selenium and diazinon as possible risk factor for osteoporosis in adult male rats.

Authors:  Monika Martiniaková; Ivana Boboňová; Radoslav Omelka; Birgit Grosskopf; Hana Chovancová; Jana Spanková; Róbert Toman
Journal:  Acta Vet Scand       Date:  2013-11-17       Impact factor: 1.695

10.  SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX-trial): study design of an international multicenter randomized double-blinded controlled trial of high dose sodium-selenite administration in high-risk cardiac surgical patients.

Authors:  Christian Stoppe; Bernard McDonald; Steffen Rex; William Manzanares; Richard Whitlock; Stephen Fremes; Robert Fowler; Yoan Lamarche; Patrick Meybohm; Christoph Haberthür; Rolf Rossaint; Andreas Goetzenich; Gunnar Elke; Andrew Day; Daren K Heyland
Journal:  Trials       Date:  2014-08-28       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.